Cloning pigs using donor nuclei from differentiated cells

Abstract

An improved method of nuclear transfer involving the transplantation of donor differentiated pig cell nuclei into enucleated pig oocytes is provided. The resultant nuclear transfer units are useful for multiplication of genotypes and transgenic genotypes by the production of fetuses and offspring. Production of genetically engineered or transgenic pig embryos, fetuses and offspring is facilitated by the present method since the differentiated cell source of the donor nuclei can be genetically modified and clonally propagated.

Description

[0001] This application is a continuation of Ser. No. 08 / 888,057, filed Jul. 3, 1997, which is a continuation-in-part of Ser. No. 08 / 781,752, filed Jan. 10, 1997, the contents of which are hereby incorporated by reference.[0002] 1. FIELD OF THE INVENTION[0003] The present invention relates to cloning procedures in which cell nuclei derived from differentiated pig cells are transplanted into enucleated mammalian oocytes of the same species as the donor nuclei. The nuclei are reprogrammed to direct the development of cloned embryos, which can then be transferred into recipient females to produce fetuses and offspring, or used to produce cultured inner cell mass cells (CICM). The cloned embryos can also be combined with fertilized embryos to produce chimeric embryos, fetuses and / or offspring.[0004] 2. BACKGROUND OF THE INVENTION[0005] The use of ungulate inner cell mass (ICM) cells for nuclear transplantation has also been reported. For example, Collas et al., Mol. Reprod. Dev., 38:264...

AI Technical Summary

Benefits of technology

[0055] Thus, according to the present invention, multiplication of superior genotypes of pigs is possible. This will allow the multiplication of adult pigs with proven genetic superiority or other desirable traits. Genetic progress will be accelerated in the pig. By the present invention, there are potentially billions of fetal or adult pig cells that can be harvested and used in the cloning procedure. This will potentially result in many identical offspring in a short period.

[0105] The present invention can thus be used to provide adult pigs with desired genotypes. Multiplication of adult pigs with proven genetic superiority or other desirable traits is particularly useful, including transgenic or genetically engineered animals, and chimeric animals. Thus, the present invention will allow production of single sex offspring, and production of pigs having improved meat production, reproductive traits and disease resistance. Furthermore, cell and tissues from the NT fetus, including transgenic and / or chimeric fetuses, can be used in cell, tissue and organ transplantation for the treatment of numerous diseases as described below in connection with the use of CICM cells. Hence, transgenic pigs have uses including models for diseases, xenotransplantation of cells and organs, and production of pharmaceutical proteins.

Problems solved by technology

However, there was no demonstration of development past early embryonic stages (blastocyst stage).

Also, granulosa cells are not easily cultured and are only obtainable from females.

Cloning pig cells is more difficult in comparison with cells of other species.

There also exist problems in the area of producing transgenic pigs.

However, many early embryos are required to produce one transgenic animal and, thus, this procedure is very inefficient.

Also, there is no simple and efficient method of selecting for a transgenic embryo before going through the time and expense of putting the embryos into surrogate females.

In addition, gene targeting techniques cannot be easily accomplished with early embryo transgenic procedures.

Even if these precautions are followed, these cells often undergo spontaneous differentiation and cannot be used to produce transgenic offspring by currently available methods.